Downregulation of p21/WAF1 is related to advanced and dedifferentiated laryngeal squamous cell carcinoma

被引:12
|
作者
Hirvikoski, P
Kellokoski, JK
Kumpulainen, EJ
Virtaniemi, JA
Johansson, RT
Kosma, VM
机构
[1] Univ Kuopio, Dept Pathol & Forens Med, FIN-70211 Kuopio, Finland
[2] Univ Kuopio, Dept Otorhinolaryngol, FIN-70211 Kuopio, Finland
[3] Univ Kuopio, Oral & Maxillofacial Unit, FIN-70211 Kuopio, Finland
[4] Kuopio Univ Hosp, Dept Oncol, Kuopio, Finland
关键词
p21/WAF1; laryngeal neoplasms; prognosis;
D O I
10.1136/jcp.52.6.440
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aim-To analyse p21/WAF1 expression and its relation to p53, apoptosis, cell proliferation, clinicopathological characteristics, and patient survival in human laryngeal squamous cell carcinoma. Methods-Primary tumours for analyses were obtained from 172 patients with complete follow up data. All patients were treated between 1975 and 1995. Immunohistochemistry was used to evaluate the expression of p21/WAF1, bcl-2, and p53 proteins. The proliferative activity was determined using Ki67 and PCNA antibodies as well as volume corrected mitotic count (M/V index). Volume corrected apoptotic count (AN index) was determined using an enzymatic in situ cell death detection kit based on the TUNEL method. Results-High p21 expression was significantly related to high p53 and normal bcl-2 expressions as well as low mitotic count. No association was noticed between p21 expression and apoptotic rate. A significant inverse correlation between p21 expression and advanced stage and poor differentiation was observed, but p21 expression showed no correlation with survival. Conclusions-The expression of p21 was associated with tumour stage, histopathological grade, node status, and mitotic count, which may indicate a role for p21 in the progression of laryngeal squamous cell carcinoma.
引用
收藏
页码:440 / 444
页数:5
相关论文
共 50 条
  • [21] P21/waf1 mutation and drug resistance to paclitaxel in locally advanced breast cancer
    Chrisanthar, Ranjan
    Knappskog, Stian
    Staalesen, Vidar
    Lillehaug, Johan Richard
    Lonning, Per Eystein
    INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (12) : 2749 - 2749
  • [22] P21/WAF1 expression and p53 mutation status in hepatocellular carcinoma.
    Ng, IOL
    Qin, LF
    Ng, M
    HEPATOLOGY, 1997, 26 (04) : 1311 - 1311
  • [23] THE EXPRESSION AND SIGNIFICANCE OF P53 AND P21(WAF1/CIP1) IN THYROID CARCINOMA
    霍雄伟
    马清涌
    高燕凤
    孙学军
    刘浩
    盛薇
    Academic Journal of Xi'an Jiaotong University, 2005, (01) : 86 - 89
  • [24] P21(WAF1/Cip1) expression is associated with cell differentiation but not with p53 mutations in squamous cell carcinomas of the larynx
    Nadal, A
    Jares, P
    Cazorla, M
    Fernandez, PL
    Sanjuan, X
    Hernandez, L
    Pinyol, M
    Aldea, M
    Mallofre, C
    Muntane, J
    Traserra, J
    Campo, E
    Cardesa, A
    JOURNAL OF PATHOLOGY, 1997, 183 (02): : 156 - 163
  • [25] Aneuploidy and low p21/WAF1 expression in malignant paragangliomas
    不详
    VIRCHOWS ARCHIV, 2005, 447 (02) : 430 - 430
  • [26] The significance of p21/waf1 in endomitosis of murine megakaryocytes.
    Ishida, Y
    Ono, Y
    Ito, T
    Kuriya, S
    Fujii, H
    BLOOD, 1997, 90 (10) : 3479 - 3479
  • [27] p21/waf1/cip1 and mdm-2 expression in breast carcinoma patients as related to prognosis
    Jiang, M
    Shao, ZM
    Wu, J
    Lu, JS
    Yu, LM
    Yuan, JD
    Han, QX
    Shen, ZZ
    Fontana, JA
    INTERNATIONAL JOURNAL OF CANCER, 1997, 74 (05) : 529 - 534
  • [28] p21(Waf1) expression in normal and pathologic colonic mucosa
    Doglioni, C
    DelTos, AP
    Pelosio, P
    Laurino, L
    Macri, E
    Meggiolaro, E
    Barbareschi, M
    LABORATORY INVESTIGATION, 1996, 74 (01) : 313 - 313
  • [29] In vivo overexpression of the cyclin-dependent kinase inhibitor, p21(waf1/clp1), in human cutaneous melanoma and squamous cell carcinoma
    Tron, VA
    Yong, WP
    Trotter, MJ
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (04) : 334 - 334
  • [30] Transcriptional regulation of the p21(WAF1/ClP1) gene
    Gartel, AL
    Tyner, AL
    EXPERIMENTAL CELL RESEARCH, 1999, 246 (02) : 280 - 289